Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
International Journal for Parasitology|April 18, 2001
Characterisation of Haemonchus contortus-derived cell populations propagated in vitro in a tissue culture environment and their potential to induce protective immunity in sheepC P Coyne, D BrakeJournal of Pharmaceutics & Drug Delivery Research|November 28, 2015
Fludarabine- (C2-methylhydroxyphosphoramide)- [anti-IGF-1R]: Synthesis and Selectively "Targeted"Anti-Neoplastic Cytotoxicity against Pulmonary Adenocarcinoma (A549)C P Coyne, Lakshmi NarayananJournal of Experimental Therapeutics & Oncology|December 28, 2019
Mebendazole in simultaneous combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR] generated utilizing a novel synthesis regimen: dual anti-neoplastic cytotoxicity against pulmonary adenocarcinoma (A549)C P Coyne, Lakshmi NarayananAmerican Journal of Veterinary Research|February 1, 1993
Inhibition of lipopolysaccharide-induced macrophage tumor necrosis factor-alpha synthesis by polymyxin B sulfateC P Coyne, B W FenwickBioorganic & Medicinal Chemistry|December 21, 2010
Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinomaC P Coyne, Toni Jones, Todd PharrCancer and Clinical Oncology|July 31, 2015
Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and Alternative Tubulin/Microtubule Inhibitors on the Cytotoxic Anti-Neoplastic Potency of Epirubicin-(C3-amide)-Anti-HER2/neu Synthesized Utilizing a UV-Photoactivated Anthracycline IntermediateC P Coyne, Toni Jones, Ryan BearMedicinal Chemistry|July 31, 2015
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3)C P Coyne, Toni Jones, Ryan BearJournal of Clinical & Experimental Oncology|August 8, 2015
Gemcitabine-(C4-amide)-[anti-HER2/neu] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary AdenocarcinomaC P Coyne, Toni Jones, Ryan BearJournal of Cancer Therapy|March 31, 2015
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-MethylselenocysteineC P Coyne, Toni Jones, Ryan BearJournal of Cancer Research and Therapeutic Oncology|April 7, 2015
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of MebendazoleC P Coyne, Toni Jones, Ryan BearPageof 4